Keymed Biosciences Inc. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Chen Bo, was filed 08 Jun 2023.
Keymed Biosciences Inc. - B: what insiders have been doing
Keymed Biosciences Inc. - B is a listed company. Filings by its managers are published through HKEX. No insider at Keymed Biosciences Inc. - B has published a filing in the past twelve months. The most recent one dates from 23 June 2025.
Looking back to 2021, when coverage begins, insiders filed 6 purchases and 6 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -22.8%Entry HK$42.75 · Close at T+365 HK$33.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Keymed Biosciences Inc. - B Strong Buy (bullish), based on 11 analysts. Average price target: HK$104.58.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 19,000,000 shares@ HK$45.4831.8% of flowShareXHKGHKEX:DA20250623E00005
- 19,000,000 shares@ HK$45.4831.8% of flowShareXHKGHKEX:DA20250616E00010
- 21,600,000 shares@ HK$45.4835.8% of flowShareXHKGHKEX:DA20250616E00011
- 114,500 shares@ HK$52.92710.2% of flowShareXHKGHKEX:DA20230915E00403
- 48,000 shares@ HK$51.67760.1% of flowShareXHKGHKEX:DA20230915E00402
- 37,500 shares@ HK$51.31870.1% of flowShareXHKGHKEX:DA20230915E00401
- 27,000 shares@ HK$40.900.0% of flowShareXHKGHKEX:DA20230608E00067Canonical exit: 5 Sept 2023 (T+90)
- 1,617,084 sharesShareXHKGHKEX:DA20220909E00160
- 7,000 shares@ HK$29.350.0% of flowShareXHKGHKEX:DA20220105E00372Canonical exit: 5 Apr 2022 (T+90)
- 14,000 shares@ HK$35.100.0% of flowShareXHKGHKEX:DA20211220E00382Canonical exit: 20 Mar 2022 (T+90)
- 16,000 shares@ HK$41.86560.0% of flowShareXHKGHKEX:DA20211207E00028Canonical exit: 6 Mar 2022 (T+90)
- 10,000 shares@ HK$46.30750.0% of flowShareXHKGHKEX:DA20211202E00047Canonical exit: 1 Mar 2022 (T+90)
- 65,000 shares@ HK$47.05380.1% of flowShareXHKGHKEX:DA20211201E00228Canonical exit: 28 Feb 2022 (T+90)
13 of 13 declarations
About Keymed Biosciences Inc. - B
Keymed Biosciences Inc. - B is a biotechnology company listed on the Hong Kong Stock Exchange, specializing in the development of innovative treatments for autoimmune diseases. It focuses on the research and commercialization of therapeutic solutions.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations